AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

TOFACITINIB CITRATE

11 registrations across 3 African markets— 11 active

Markets with TOFACITINIB CITRATE

Recent registrations

Brand / ProductMarketHolderStatusExpires
RITRI 5
Film-Coated Tablet
🇰🇪KenyaOMILIFE LIMITEDactiveOct 2028
RITRI 10
Film-Coated Tablet
🇰🇪KenyaOMILIFE LIMITEDactiveOct 2028
Xeltin Tablets
Film-Coated Tablet
🇰🇪KenyaAjanta Pharma LimitedactiveMar 2027
TOFACITINIB CITRATE
ORAL SOLID ORDINARY FILM- COATED TABLETS
🇺🇬UgandaAJANTA PHARMA LIMITEDactive
TOFACITINIB CITRATE
ORAL SOLID ORDINARY FILM- COATED TABLETS
🇺🇬UgandaAJANTA PHARMA LIMITEDactive
Xeltin
Tablets
🇹🇿TanzaniaAjanta Pharma Limitedactive
Tofacitinib Pfizer 5 mg
Tablets
🇹🇿TanzaniaPfizer Laboratories Limitedactive
TOFACITINIB CITRATE
ORAL SOLID ORDINARY FILM- COATED TABLETS
🇺🇬UgandaAJANTA PHARMA LIMITEDactive
Povidone Iodine
Solution
🇹🇿TanzaniaPrince Pharmaceuticals Co. Ltdactive
JITRIT-5
Film Coated Tablet
🇹🇿TanzaniaMicro Labs Limitedactive
TOFACITINIB CITRATE
ORAL SOLID ORDINARY FILM- COATED TABLETS
🇺🇬UgandaAJANTA PHARMA LIMITEDactive

TOFACITINIB CITRATE in Africa — Regulatory Overview

TOFACITINIB CITRATE is registered across 3 African markets with 11 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tanzania, Uganda, Kenya. AfricaRegulatory refreshes this data daily from official government sources.

Of the 11 registrations, 11 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.